HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.765
-0.182 (-19.24%)
Nov 21, 2024, 12:38 PM EST - Market open
HCW Biologics Employees
HCW Biologics had 45 employees as of December 31, 2023. The number of employees increased by 1 or 2.27% compared to the previous year.
Employees
45
Change (1Y)
1
Growth (1Y)
2.27%
Revenue / Employee
$77,689
Profits / Employee
-$829,579
Market Cap
28.93M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45 | 1 | 2.27% |
Dec 31, 2022 | 44 | 0 | - |
Dec 31, 2021 | 44 | 4 | 10.00% |
Dec 31, 2020 | 40 | - | - |
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
Barinthus Biotherapeutics | 130 |
Carisma Therapeutics | 107 |
Beyond Air | 107 |
Tonix Pharmaceuticals Holding | 103 |
Precision Optics Corporation | 85 |
NextCure | 82 |
Elevation Oncology | 29 |
HCWB News
- 2 days ago - HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - GlobeNewsWire
- 3 days ago - Why Is Penny Stock HCW Biologics Surging On Monday? - Benzinga
- 3 days ago - HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewsWire
- 6 days ago - HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction - GlobeNewsWire
- 3 months ago - HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 6 months ago - HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 8 months ago - HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights - GlobeNewsWire